Infants with leukemia inherit susceptibility

February 19, 2014 by Caroline Arbanas
Infants with leukemia inherit susceptibility
Infant leukemia is a rare but devastating illness. New research by Todd Druley, MD, PhD, indicates that babies with leukemia have inherited a genetic predisposition that makes them highly susceptible to the disease. Credit: Steve Dolan

(Medical Xpress)—Babies who develop leukemia during the first year of life appear to have inherited an unfortunate combination of genetic variations that may make the infants highly susceptible to the disease, according to a new study at Washington University School of Medicine in St. Louis and the University of Minnesota.

The research is available online in the journal Leukemia.

Doctors have long puzzled over why it is that babies just a few months old sometimes develop cancer. As infants, they have not lived long enough to accumulate a critical number of cancer-causing mutations.

"Parents always ask why their child has developed , and unfortunately we have had few answers," said senior author Todd Druley, MD, PhD, a Washington University pediatric oncologist who treats patients at St. Louis Children's Hospital. "Our study suggests that babies with leukemia inherit a strong genetic predisposition to the disease."

The babies appear to have inherited rare genetic variants from both parents that by themselves would not cause problems, but in combination put the infants at high risk of leukemia. These variants most often occurred in genes known to be linked to leukemia in children, said Druley, an assistant professor of pediatrics.

Leukemia occurs rarely in infants, with only about 160 cases diagnosed annually in the United States. But unlike leukemia in children, which most often can be cured, about half of infants who develop leukemia die of the disease.

The researchers sequenced all the genes in the DNA of healthy cells from 23 infants with leukemia and their mothers. Looking at genes in the healthy cells helped the researchers understand which genetic variations were passed from a mother to her child, and by process of elimination, the scientists could determine the father's contribution to a baby's DNA.

Among the families studied, there was no history of pediatric cancers. The scientists also sequenced the DNA of 25 healthy children as a comparison.

"We sequenced every single gene and found that infants with leukemia were born with an excess of damaging changes in genes known to be linked to leukemia," Druley said. "For each child, both parents carried a few harmful genetic variations in their DNA, and just by chance their child inherited all of these changes."

Other children in the families typically don't develop leukemia because a roll of the genetic dice likely means they did not inherit the same combination of harmful genetic changes, he added.

Druley said it's unlikely that the inherited variations alone cause cancer to develop in infants. Rather, the babies likely only needed to accumulate very few additional genetic errors in cells of the bone marrow, where leukemia originates, to develop the cancer in such a short time span.

He and his colleagues now want to study the inherited variations in more detail to understand how they contribute to the development of leukemia. Eventually, with additional research, it may be possible to use a technique called genetic editing to "cut" the harmful gene from the DNA of who are susceptible to leukemia and replace it with a healthy version of the same gene, thereby sparing babies and their families from a devastating diagnosis.

Druley, along with his Washington University colleagues in genetics and oncology, also have established the region's first Pediatric Cancer Predisposition Clinic, located at St. Louis Children's Hospital. The team closely follows children with an increased risk of cancer to increase the likelihood that cancers are detected and treated early.

Physical and occupational therapists, audiologists and other health professionals also are available to provide support services to the children. Genetic research conducted through the clinic is designed to improve the surveillance of and understanding of how and why they develop.

Explore further: Rare, inherited mutation leaves children susceptible to acute lymphoblastic leukemia

More information: Valentine MC, Linaberry AM, Chasnoff S, Hughes AEO, Mallaney C, Sanchez N, Giacalone J, Heerema NA, Hilden JM, Spector LG, Ross JA and Druley TE. Excess congenital non-synonymous variation in leukemia-associated genes in MLL-infant leukemia: a children's oncology group report. Leukemia. Advance online publication, Jan. 10, 2014.

Related Stories

Rare, inherited mutation leaves children susceptible to acute lymphoblastic leukemia

October 15, 2013
(Medical Xpress)—Researchers have discovered the first inherited gene mutation linked exclusively to acute lymphoblastic leukemia (ALL) occurring in multiple relatives in individual families. The discovery of the PAX5 gene ...

Researchers uncover genetic cause of childhood leukemia

September 8, 2013
For the first time, a genetic link specific to risk of childhood leukemia has been identified, according to a team of researchers from Memorial Sloan-Kettering Cancer Center, St. Jude Children's Research Hospital, University ...

Inherited gene variation tied to high-risk pediatric leukemia and greater risk of relapse

October 20, 2013
Research led by St. Jude Children's Research Hospital scientists has linked an inherited gene variation to a nearly four-fold increased risk of developing a pediatric acute lymphoblastic leukemia (ALL) subtype that is associated ...

Rare form of leukemia found to originate in stem cells

February 13, 2014
(Medical Xpress)—An international team of researchers working out of the University of Toronto has found that one type of rare leukemia appears to get its start in stem cells. In their paper published in the journal Nature, ...

A genetic defect in sex cells may predispose to childhood leukemia

December 17, 2012
Researchers at the Sainte-Justine University Hospital Center and the University of Montreal have found a possible heredity mechanism that predisposes children to acute lymphoblastic leukemia (ALL), the most common type of ...

A promising new approach for treating leukemia discovered

February 13, 2014
A group of researchers at the Institute for Research in Immunology and Cancer (IRIC) of Université de Montréal discovered a promising new approach to treating leukemia by disarming a gene that is responsible for tumor progression. ...

Recommended for you

Study may explain failure of retinoic acid trials against breast cancer

July 25, 2017
Estrogen-positive breast cancers are often treated with anti-estrogen therapies. But about half of these cancers contain a subpopulation of cells marked by the protein cytokeratin 5 (CK5), which resists treatment—and breast ...

Physical activity could combat fatigue, cognitive decline in cancer survivors

July 25, 2017
A new study indicates that cancer patients and survivors have a ready weapon against fatigue and "chemo brain": a brisk walk.

Breaking the genetic resistance of lung cancer and melanoma

July 25, 2017
Researchers from Monash University and the Memorial Sloan Kettering Cancer Center (MSKCC, New York) have discovered why some cancers – particularly lung cancer and melanoma – are able to quickly develop deadly resistance ...

New therapeutic approach for difficult-to-treat subtype of ovarian cancer identified

July 24, 2017
A potential new therapeutic strategy for a difficult-to-treat form of ovarian cancer has been discovered by Wistar scientists. The findings were published online in Nature Cell Biology.

Immune cells the missing ingredient in new bladder cancer treatment

July 24, 2017
New research offers a possible explanation for why a new type of cancer treatment hasn't been working as expected against bladder cancer.

Anti-cancer chemotherapeutic agent inhibits glioblastoma growth and radiation resistance

July 24, 2017
Glioblastoma is a primary brain tumor with dismal survival rates, even after treatment with surgery, chemotherapy and radiation. A small subpopulation of tumor cells—glioma stem cells—is responsible for glioblastoma's ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.